Annual Accounts Payable
$8.72 M
+$6.82 M+360.49%
December 31, 2023
Summary
- As of February 10, 2025, RPHM annual accounts payable is $8.72 million, with the most recent change of +$6.82 million (+360.49%) on December 31, 2023.
- During the last 3 years, RPHM annual accounts payable has risen by +$7.81 million (+860.02%).
Performance
RPHM Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$64.00 K
-$612.00 K-90.53%
June 30, 2024
Summary
- As of February 10, 2025, RPHM quarterly accounts payable is $64.00 thousand, with the most recent change of -$612.00 thousand (-90.53%) on June 30, 2024.
- Over the past year, RPHM quarterly accounts payable has dropped by -$8.65 million (-99.27%).
Performance
RPHM Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RPHM Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +360.5% | -99.3% |
| 3 y3 years | +860.0% | -95.9% |
| 5 y5 years | +1508.3% | -88.5% |
RPHM Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -78.3% | -99.3% | at low |
| 5 y | 5-year | at high | -93.8% | -99.3% | at low |
| alltime | all time | at high | -93.8% | -99.3% | at low |
Reneo Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $64.00 K(-90.5%) |
| Mar 2024 | - | $676.00 K(-92.2%) |
| Dec 2023 | $8.72 M(+360.5%) | $8.72 M(+252.5%) |
| Sep 2023 | - | $2.47 M(+35.3%) |
| Jun 2023 | - | $1.83 M(+1.4%) |
| Mar 2023 | - | $1.80 M(-4.8%) |
| Dec 2022 | $1.89 M | $1.89 M(-13.5%) |
| Sep 2022 | - | $2.19 M(+40.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $1.56 M(-0.4%) |
| Mar 2022 | - | $1.57 M(-22.6%) |
| Dec 2021 | $2.02 M(+122.7%) | $2.02 M(+59.1%) |
| Sep 2021 | - | $1.27 M(+192.9%) |
| Jun 2021 | - | $434.00 K(-21.9%) |
| Mar 2021 | - | $556.00 K(-38.8%) |
| Dec 2020 | $908.00 K(+67.5%) | - |
| Dec 2020 | - | $908.00 K |
| Dec 2019 | $542.00 K | - |
FAQ
- What is Reneo Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals annual accounts payable year-on-year change?
- What is Reneo Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Reneo Pharmaceuticals?
- What is Reneo Pharmaceuticals quarterly accounts payable year-on-year change?
What is Reneo Pharmaceuticals annual accounts payable?
The current annual accounts payable of RPHM is $8.72 M
What is the all time high annual accounts payable for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high annual accounts payable is $8.72 M
What is Reneo Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, RPHM annual accounts payable has changed by +$6.82 M (+360.49%)
What is Reneo Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of RPHM is $64.00 K
What is the all time high quarterly accounts payable for Reneo Pharmaceuticals?
Reneo Pharmaceuticals all-time high quarterly accounts payable is $8.72 M
What is Reneo Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, RPHM quarterly accounts payable has changed by -$8.65 M (-99.27%)